| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.95e-06 | 18 | 40 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.34e-05 | 4 | 40 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.22e-05 | 31 | 40 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.90e-05 | 33 | 40 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 5.84e-05 | 6 | 40 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 5.84e-05 | 6 | 40 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.20e-04 | 627 | 40 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 2.55e-04 | 12 | 40 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 3.01e-04 | 13 | 40 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.03e-04 | 465 | 40 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.12e-04 | 664 | 40 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.83e-04 | 343 | 40 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 6.90e-04 | 758 | 40 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 7.27e-04 | 20 | 40 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 8.81e-04 | 22 | 40 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 9.00e-04 | 793 | 40 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.13e-03 | 230 | 40 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.43e-03 | 28 | 40 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.83e-03 | 262 | 40 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.87e-03 | 32 | 40 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.87e-03 | 32 | 40 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.05e-03 | 1180 | 40 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.09e-03 | 127 | 40 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.13e-03 | 459 | 40 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.19e-03 | 129 | 40 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.49e-03 | 37 | 40 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.76e-03 | 140 | 40 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.41e-03 | 151 | 40 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | transporter activity | 3.55e-03 | 1289 | 40 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | channel activity | 3.80e-03 | 525 | 40 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.83e-03 | 526 | 40 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.83e-03 | 171 | 40 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 6.23e-03 | 59 | 40 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.75e-03 | 193 | 40 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.15e-03 | 197 | 40 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.31e-03 | 614 | 40 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 7.55e-03 | 201 | 40 | 3 | GO:0061135 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix disassembly | 8.03e-07 | 10 | 40 | 3 | GO:0090091 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix disassembly | 1.51e-05 | 25 | 40 | 3 | GO:0010715 | |
| GeneOntologyBiologicalProcess | circadian regulation of translation | 2.19e-05 | 4 | 40 | 2 | GO:0097167 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.65e-05 | 5 | 40 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.65e-05 | 5 | 40 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 3.65e-05 | 5 | 40 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 3.65e-05 | 5 | 40 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 3.88e-05 | 34 | 40 | 3 | GO:1903055 | |
| GeneOntologyBiologicalProcess | chromosome organization | 4.31e-05 | 686 | 40 | 8 | GO:0051276 | |
| GeneOntologyBiologicalProcess | exit from mitosis | 5.02e-05 | 37 | 40 | 3 | GO:0010458 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 5.36e-05 | 1157 | 40 | 10 | GO:0006812 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 5.93e-05 | 356 | 40 | 6 | GO:0098813 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 6.35e-05 | 40 | 40 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | circulatory system process | 6.87e-05 | 733 | 40 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | negative regulation of toll-like receptor 2 signaling pathway | 7.65e-05 | 7 | 40 | 2 | GO:0034136 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.00e-04 | 1000 | 40 | 9 | GO:0030001 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.26e-04 | 254 | 40 | 5 | GO:0000819 | |
| GeneOntologyBiologicalProcess | catagen | 1.31e-04 | 9 | 40 | 2 | GO:0042637 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 1.84e-04 | 438 | 40 | 6 | GO:0032970 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.99e-04 | 11 | 40 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.99e-04 | 11 | 40 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | regulation of wound healing, spreading of epidermal cells | 1.99e-04 | 11 | 40 | 2 | GO:1903689 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 2.23e-04 | 1374 | 40 | 10 | GO:0006811 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.39e-04 | 12 | 40 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 2.55e-04 | 465 | 40 | 6 | GO:0007059 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 2 signaling pathway | 2.82e-04 | 13 | 40 | 2 | GO:0034135 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.95e-04 | 166 | 40 | 4 | GO:0014074 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 3.09e-04 | 912 | 40 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 3.29e-04 | 14 | 40 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 3.32e-04 | 922 | 40 | 8 | GO:0098662 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix assembly | 3.79e-04 | 15 | 40 | 2 | GO:1901203 | |
| GeneOntologyBiologicalProcess | embryonic body morphogenesis | 3.79e-04 | 15 | 40 | 2 | GO:0010172 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 3.84e-04 | 942 | 40 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 3.95e-04 | 713 | 40 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 4.14e-04 | 75 | 40 | 3 | GO:0022617 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 4.90e-04 | 17 | 40 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 5.50e-04 | 18 | 40 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 5.77e-04 | 84 | 40 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 6.14e-04 | 19 | 40 | 2 | GO:0051284 | |
| GeneOntologyBiologicalProcess | toll-like receptor 2 signaling pathway | 6.14e-04 | 19 | 40 | 2 | GO:0034134 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 6.39e-04 | 1017 | 40 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | regulation of gastrulation | 6.82e-04 | 20 | 40 | 2 | GO:0010470 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 7.42e-04 | 212 | 40 | 4 | GO:0000070 | |
| GeneOntologyBiologicalProcess | gastrulation | 7.42e-04 | 212 | 40 | 4 | GO:0007369 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 7.52e-04 | 21 | 40 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | response to caffeine | 7.52e-04 | 21 | 40 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 8.09e-04 | 217 | 40 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 8.39e-04 | 384 | 40 | 5 | GO:0032956 | |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 8.78e-04 | 97 | 40 | 3 | GO:0048041 | |
| GeneOntologyBiologicalProcess | activation of protein kinase activity | 8.78e-04 | 97 | 40 | 3 | GO:0032147 | |
| GeneOntologyBiologicalProcess | hair cycle phase | 9.04e-04 | 23 | 40 | 2 | GO:0044851 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 9.59e-04 | 100 | 40 | 3 | GO:0043242 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 1.07e-03 | 25 | 40 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 1.07e-03 | 25 | 40 | 2 | GO:0043153 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 1.07e-03 | 25 | 40 | 2 | GO:0003214 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.07e-03 | 25 | 40 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | microtubule anchoring | 1.07e-03 | 25 | 40 | 2 | GO:0034453 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.16e-03 | 1115 | 40 | 8 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 1.17e-03 | 107 | 40 | 3 | GO:0051492 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 1.20e-03 | 108 | 40 | 3 | GO:0007044 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of epidermal cells | 1.34e-03 | 28 | 40 | 2 | GO:0035313 | |
| GeneOntologyBiologicalProcess | photoperiodism | 1.34e-03 | 28 | 40 | 2 | GO:0009648 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.44e-03 | 115 | 40 | 3 | GO:0150115 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix assembly | 1.44e-03 | 29 | 40 | 2 | GO:1901201 | |
| GeneOntologyBiologicalProcess | hair follicle maturation | 1.44e-03 | 29 | 40 | 2 | GO:0048820 | |
| GeneOntologyBiologicalProcess | DNA repair | 1.45e-03 | 648 | 40 | 6 | GO:0006281 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.45e-03 | 648 | 40 | 6 | GO:0008015 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 1.54e-03 | 30 | 40 | 2 | GO:0009649 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.56e-03 | 259 | 40 | 4 | GO:0051651 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 1.70e-03 | 122 | 40 | 3 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 1.74e-03 | 123 | 40 | 3 | GO:0032231 | |
| GeneOntologyBiologicalProcess | regulation of hair cycle | 1.75e-03 | 32 | 40 | 2 | GO:0042634 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 1.82e-03 | 125 | 40 | 3 | GO:0043279 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.91e-03 | 127 | 40 | 3 | GO:0043149 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.91e-03 | 127 | 40 | 3 | GO:0030038 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.94e-03 | 275 | 40 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition | 2.04e-03 | 130 | 40 | 3 | GO:0010717 | |
| GeneOntologyBiologicalProcess | mismatch repair | 2.10e-03 | 35 | 40 | 2 | GO:0006298 | |
| GeneOntologyBiologicalProcess | cell division | 2.10e-03 | 697 | 40 | 6 | GO:0051301 | |
| GeneOntologyCellularComponent | kinetochore microtubule | 9.75e-06 | 22 | 40 | 3 | GO:0005828 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 3.56e-05 | 5 | 40 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | basal cortex | 7.45e-05 | 7 | 40 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | NSL complex | 1.94e-04 | 11 | 40 | 2 | GO:0044545 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.86e-04 | 307 | 40 | 5 | GO:0000793 | |
| GeneOntologyCellularComponent | spindle microtubule | 5.95e-04 | 86 | 40 | 3 | GO:0005876 | |
| GeneOntologyCellularComponent | basal part of cell | 7.36e-04 | 378 | 40 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.04e-03 | 25 | 40 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.31e-03 | 28 | 40 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | microtubule end | 2.40e-03 | 38 | 40 | 2 | GO:1990752 | |
| GeneOntologyCellularComponent | microtubule | 3.33e-03 | 533 | 40 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.36e-03 | 45 | 40 | 2 | GO:1902562 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 3.36e-03 | 45 | 40 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | cell cortex region | 3.36e-03 | 45 | 40 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 3.50e-03 | 46 | 40 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | dynein complex | 4.80e-03 | 54 | 40 | 2 | GO:0030286 | |
| GeneOntologyCellularComponent | cytoplasmic region | 4.85e-03 | 360 | 40 | 4 | GO:0099568 | |
| GeneOntologyCellularComponent | kinetochore | 4.99e-03 | 181 | 40 | 3 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 5.96e-03 | 193 | 40 | 3 | GO:0000779 | |
| Domain | DUF3776 | 4.25e-06 | 2 | 39 | 2 | PF12618 | |
| Domain | DUF3776 | 4.25e-06 | 2 | 39 | 2 | IPR022255 | |
| Domain | Ryanrecept_TM4-6 | 1.27e-05 | 3 | 39 | 2 | IPR009460 | |
| Domain | Period_circadian-like_C | 1.27e-05 | 3 | 39 | 2 | IPR022728 | |
| Domain | RyR | 1.27e-05 | 3 | 39 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.27e-05 | 3 | 39 | 2 | IPR003032 | |
| Domain | Period_C | 1.27e-05 | 3 | 39 | 2 | PF12114 | |
| Domain | RR_TM4-6 | 1.27e-05 | 3 | 39 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.27e-05 | 3 | 39 | 2 | IPR013333 | |
| Domain | CLASP_N | 2.54e-05 | 4 | 39 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 2.54e-05 | 4 | 39 | 2 | IPR024395 | |
| Domain | Na/HCO3_transpt | 4.23e-05 | 5 | 39 | 2 | IPR003024 | |
| Domain | RIH_assoc | 6.34e-05 | 6 | 39 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 6.34e-05 | 6 | 39 | 2 | IPR013662 | |
| Domain | RIH_dom | 6.34e-05 | 6 | 39 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 6.34e-05 | 6 | 39 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 6.34e-05 | 6 | 39 | 2 | IPR015925 | |
| Domain | - | 6.34e-05 | 6 | 39 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 6.34e-05 | 6 | 39 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 6.34e-05 | 6 | 39 | 2 | PF08709 | |
| Domain | Ion_trans_dom | 9.18e-05 | 114 | 39 | 4 | IPR005821 | |
| Domain | Ion_trans | 9.18e-05 | 114 | 39 | 4 | PF00520 | |
| Domain | Band3_cytoplasmic_dom | 1.52e-04 | 9 | 39 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.52e-04 | 9 | 39 | 2 | PF07565 | |
| Domain | - | 1.52e-04 | 9 | 39 | 2 | 3.40.1100.10 | |
| Domain | MIR | 1.89e-04 | 10 | 39 | 2 | PS50919 | |
| Domain | MIR | 1.89e-04 | 10 | 39 | 2 | PF02815 | |
| Domain | MIR | 1.89e-04 | 10 | 39 | 2 | SM00472 | |
| Domain | HCO3_cotransp | 1.89e-04 | 10 | 39 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.89e-04 | 10 | 39 | 2 | IPR011531 | |
| Domain | MIR_motif | 1.89e-04 | 10 | 39 | 2 | IPR016093 | |
| Domain | PTrfase/Anion_transptr | 1.89e-04 | 10 | 39 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.89e-04 | 10 | 39 | 2 | IPR003020 | |
| Domain | Zinc_finger_PHD-type_CS | 3.36e-04 | 65 | 39 | 3 | IPR019786 | |
| Domain | PAS_fold_3 | 1.05e-03 | 23 | 39 | 2 | IPR013655 | |
| Domain | PAS_3 | 1.05e-03 | 23 | 39 | 2 | PF08447 | |
| Domain | ZF_PHD_1 | 1.05e-03 | 96 | 39 | 3 | PS01359 | |
| Domain | PAS-assoc_C | 1.14e-03 | 24 | 39 | 2 | IPR000700 | |
| Domain | PAC | 1.34e-03 | 26 | 39 | 2 | IPR001610 | |
| Domain | PAC | 1.34e-03 | 26 | 39 | 2 | SM00086 | |
| Domain | PAC | 1.34e-03 | 26 | 39 | 2 | PS50113 | |
| Domain | TUDOR | 1.44e-03 | 27 | 39 | 2 | SM00333 | |
| Domain | Tudor | 1.78e-03 | 30 | 39 | 2 | IPR002999 | |
| Domain | PAS | 2.03e-03 | 32 | 39 | 2 | SM00091 | |
| Domain | PAS | 2.29e-03 | 34 | 39 | 2 | IPR000014 | |
| Domain | PAS | 2.29e-03 | 34 | 39 | 2 | PS50112 | |
| Domain | Znf_FYVE_PHD | 3.55e-03 | 147 | 39 | 3 | IPR011011 | |
| Domain | EF-hand_1 | 3.90e-03 | 152 | 39 | 3 | PF00036 | |
| Domain | - | 4.21e-03 | 746 | 39 | 6 | 3.40.50.300 | |
| Domain | HEAT | 4.51e-03 | 48 | 39 | 2 | PF02985 | |
| Domain | ARM-type_fold | 5.32e-03 | 339 | 39 | 4 | IPR016024 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.42e-05 | 271 | 33 | 6 | MM15388 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 5.09e-05 | 291 | 33 | 6 | M16647 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.35e-04 | 681 | 33 | 8 | MM14985 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 1.47e-04 | 8 | 33 | 2 | M27351 | |
| Pathway | REACTOME_CELL_CYCLE | 1.54e-04 | 694 | 33 | 8 | M543 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.30e-04 | 736 | 33 | 8 | M27287 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 2.36e-04 | 10 | 33 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 2.36e-04 | 10 | 33 | 2 | MM15073 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.08e-04 | 13 | 33 | 2 | M39589 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 4.08e-04 | 13 | 33 | 2 | M18009 | |
| Pathway | REACTOME_CELL_CYCLE | 4.09e-04 | 603 | 33 | 7 | MM14635 | |
| Pathway | PID_CIRCADIAN_PATHWAY | 6.25e-04 | 16 | 33 | 2 | M95 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.86e-04 | 19 | 33 | 2 | M47760 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 9.83e-04 | 191 | 33 | 4 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.02e-03 | 193 | 33 | 4 | MM14890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.19e-03 | 22 | 33 | 2 | M47903 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.21e-03 | 202 | 33 | 4 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.25e-03 | 204 | 33 | 4 | M4217 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.57e-03 | 99 | 33 | 3 | MM14910 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.62e-03 | 100 | 33 | 3 | MM14561 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.58e-07 | 1105 | 40 | 10 | 35748872 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28568893 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28710114 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16914514 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23977055 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22236088 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22238756 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21793695 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27021954 | ||
| Pubmed | Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. | 1.29e-06 | 2 | 40 | 2 | 24551282 | |
| Pubmed | Constant darkness is a circadian metabolic signal in mammals. | 1.29e-06 | 2 | 40 | 2 | 16421573 | |
| Pubmed | Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. | 1.29e-06 | 2 | 40 | 2 | 11389837 | |
| Pubmed | Circadian regulation of central ethanol sensitivity by the mPer2 gene. | 1.29e-06 | 2 | 40 | 2 | 19523042 | |
| Pubmed | Cocaine sensitization and reward are under the influence of circadian genes and rhythm. | 1.29e-06 | 2 | 40 | 2 | 12084940 | |
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 1.29e-06 | 2 | 40 | 2 | 12837247 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 11207804 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.29e-06 | 2 | 40 | 2 | 21531043 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15009158 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35475497 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16678258 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 20370466 | ||
| Pubmed | cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. | 1.29e-06 | 2 | 40 | 2 | 18487196 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35810166 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23110090 | ||
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 1.29e-06 | 2 | 40 | 2 | 16866869 | |
| Pubmed | Circadian Modulation of Neurons and Astrocytes Controls Synaptic Plasticity in Hippocampal Area CA1. | 1.29e-06 | 2 | 40 | 2 | 33053337 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24603368 | ||
| Pubmed | The circadian clock protects against ionizing radiation-induced cardiotoxicity. | 1.29e-06 | 2 | 40 | 2 | 31919902 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12775559 | ||
| Pubmed | Circadian time-dependent tumor suppressor function of period genes. | 1.29e-06 | 2 | 40 | 2 | 19926612 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17996461 | ||
| Pubmed | Circadian gene expression is resilient to large fluctuations in overall transcription rates. | 1.29e-06 | 2 | 40 | 2 | 19078963 | |
| Pubmed | The circadian clock and tumor suppression by mammalian period genes. | 1.29e-06 | 2 | 40 | 2 | 15817328 | |
| Pubmed | Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing? | 1.29e-06 | 2 | 40 | 2 | 18367514 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19701196 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21773940 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22910690 | ||
| Pubmed | Homeostatic sleep regulation is preserved in mPer1 and mPer2 mutant mice. | 1.29e-06 | 2 | 40 | 2 | 12383239 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19477955 | ||
| Pubmed | Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects. | 1.29e-06 | 2 | 40 | 2 | 23351077 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23285241 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34160105 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8898078 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24211587 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35460695 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12054191 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9920673 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36724252 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15959842 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19840112 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30452546 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17202855 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12693867 | ||
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 1.29e-06 | 2 | 40 | 2 | 10899121 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14550562 | ||
| Pubmed | Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. | 1.29e-06 | 2 | 40 | 2 | 23039899 | |
| Pubmed | Cones are required for normal temporal responses to light of phase shifts and clock gene expression. | 1.29e-06 | 2 | 40 | 2 | 20560710 | |
| Pubmed | Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice. | 1.29e-06 | 2 | 40 | 2 | 21624349 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31260634 | ||
| Pubmed | Phase shifts and Per gene expression in mouse suprachiasmatic nucleus. | 1.29e-06 | 2 | 40 | 2 | 12824769 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12372028 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28286126 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26862173 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 18786554 | ||
| Pubmed | Physiological and Molecular Dissection of Daily Variance in Exercise Capacity. | 1.29e-06 | 2 | 40 | 2 | 31006590 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36361751 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24091726 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30242505 | ||
| Pubmed | Deregulated expression of the Per1 and Per2 in human gliomas. | 1.29e-06 | 2 | 40 | 2 | 20481271 | |
| Pubmed | Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. | 1.29e-06 | 2 | 40 | 2 | 17971899 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33123539 | ||
| Pubmed | Time-place learning and memory persist in mice lacking functional Per1 and Per2 clock genes. | 1.29e-06 | 2 | 40 | 2 | 24336415 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23024437 | ||
| Pubmed | The circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels. | 1.29e-06 | 2 | 40 | 2 | 23608482 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14985349 | ||
| Pubmed | Circadian rhythms in Per1, PER2 and Ca2+ of a solitary SCN neuron cultured on a microisland. | 1.29e-06 | 2 | 40 | 2 | 31797953 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17715397 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36350921 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24770415 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27609640 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17055980 | ||
| Pubmed | Daily variation in global and local DNA methylation in mouse livers. | 1.29e-06 | 2 | 40 | 2 | 25689298 | |
| Pubmed | Per1/Per2 Disruption Reduces Testosterone Synthesis and Impairs Fertility in Elderly Male Mice. | 1.29e-06 | 2 | 40 | 2 | 35806403 | |
| Pubmed | Chronic circadian disturbance by a shortened light-dark cycle increases mortality. | 1.29e-06 | 2 | 40 | 2 | 22154820 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12531511 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 18346860 | ||
| Pubmed | Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. | 3.87e-06 | 3 | 40 | 2 | 19013183 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 18403125 | ||
| Pubmed | PER1 interaction with GPX1 regulates metabolic homeostasis under oxidative stress. | 3.87e-06 | 3 | 40 | 2 | 32896721 | |
| Pubmed | Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2. | 3.87e-06 | 3 | 40 | 2 | 11165242 | |
| Pubmed | Clock proteins and training modify exercise capacity in a daytime-dependent manner. | 3.87e-06 | 3 | 40 | 2 | 34426495 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 29626648 | ||
| Pubmed | A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. | 3.87e-06 | 3 | 40 | 2 | 9428527 | |
| Pubmed | CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development. | 3.87e-06 | 3 | 40 | 2 | 28285824 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 26781276 | ||
| Pubmed | Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. | 3.87e-06 | 3 | 40 | 2 | 9427249 | |
| Pubmed | Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network. | 3.87e-06 | 3 | 40 | 2 | 17543864 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 18434746 | ||
| Pubmed | Association between polymorphisms in period genes and bone density in postmenopausal Korean women. | 3.87e-06 | 3 | 40 | 2 | 24678593 | |
| Pubmed | Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations. | 3.87e-06 | 3 | 40 | 2 | 27912059 | |
| Interaction | PER3 interactions | 1.22e-05 | 24 | 38 | 3 | int:PER3 | |
| Interaction | H2AP interactions | 1.69e-05 | 82 | 38 | 4 | int:H2AP | |
| Interaction | RP2 interactions | 3.02e-05 | 95 | 38 | 4 | int:RP2 | |
| Interaction | CENPE interactions | 4.65e-05 | 106 | 38 | 4 | int:CENPE | |
| Interaction | TOP3B interactions | PER1 GRAMD2A CLASP2 ABCA2 WDR36 PER2 ARID1A BCR PROM2 MFHAS1 CHD5 | 5.72e-05 | 1470 | 38 | 11 | int:TOP3B |
| Cytoband | 15q23 | 6.84e-04 | 44 | 40 | 2 | 15q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q43 | 1.35e-03 | 62 | 40 | 2 | chr1q43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q23 | 1.63e-03 | 68 | 40 | 2 | chr15q23 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.50e-06 | 3 | 25 | 2 | 287 | |
| GeneFamily | Dyneins, axonemal | 2.46e-04 | 17 | 25 | 2 | 536 | |
| GeneFamily | PHD finger proteins | 2.53e-04 | 90 | 25 | 3 | 88 | |
| GeneFamily | Tudor domain containing | 1.19e-03 | 37 | 25 | 2 | 780 | |
| GeneFamily | EF-hand domain containing | 3.31e-03 | 219 | 25 | 3 | 863 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP | 1.21e-05 | 197 | 40 | 5 | M9817 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TCONV_UP | 1.30e-05 | 200 | 40 | 5 | M3234 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.10e-05 | 402 | 40 | 6 | MM454 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 8.63e-05 | 56 | 40 | 3 | M3576 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.06e-04 | 60 | 40 | 3 | MM654 | |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 1.08e-04 | 162 | 40 | 4 | M6387 | |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 1.76e-04 | 184 | 40 | 4 | M8990 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.99e-04 | 190 | 40 | 4 | M761 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_UP | 2.29e-04 | 197 | 40 | 4 | M9997 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 2.33e-04 | 198 | 40 | 4 | M8274 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN | 2.33e-04 | 198 | 40 | 4 | M4202 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 2.38e-04 | 199 | 40 | 4 | M8031 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN | 2.38e-04 | 199 | 40 | 4 | M4525 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.38e-04 | 199 | 40 | 4 | M5893 | |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_UP | 2.38e-04 | 199 | 40 | 4 | M9017 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_DN | 2.38e-04 | 199 | 40 | 4 | M5567 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B2_BCELL_DN | 2.42e-04 | 200 | 40 | 4 | M6464 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN | 2.42e-04 | 200 | 40 | 4 | M4593 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP | 2.42e-04 | 200 | 40 | 4 | M8957 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 2.42e-04 | 200 | 40 | 4 | M4531 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 2.42e-04 | 200 | 40 | 4 | M7019 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.42e-04 | 200 | 40 | 4 | M9120 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 197 | 40 | 5 | 25bbe270d0897b9b1bd00d205f66efd1def81b99 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 168 | 40 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-05 | 55 | 40 | 3 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 173 | 40 | 4 | 20a20429aa898097d5ec4880ed64846558b5890f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-05 | 175 | 40 | 4 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.07e-05 | 181 | 40 | 4 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 181 | 40 | 4 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.07e-05 | 181 | 40 | 4 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 181 | 40 | 4 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.16e-05 | 183 | 40 | 4 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 183 | 40 | 4 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-05 | 185 | 40 | 4 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.30e-05 | 186 | 40 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.40e-05 | 188 | 40 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 188 | 40 | 4 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 191 | 40 | 4 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 191 | 40 | 4 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 191 | 40 | 4 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-05 | 193 | 40 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 195 | 40 | 4 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.94e-05 | 198 | 40 | 4 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Sigmoid / Region, Cell class and subclass | 3.00e-05 | 199 | 40 | 4 | bd6f8c0f79e9a94cc0f8c6105d38851463de821c | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs|Sigmoid / shred on region, Cell_type, and subtype | 3.00e-05 | 199 | 40 | 4 | 8ee78a39729633bcbb3ab17e1dfaca33f38db569 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.05e-05 | 200 | 40 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-05 | 200 | 40 | 4 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-05 | 200 | 40 | 4 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.05e-05 | 200 | 40 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.05e-05 | 200 | 40 | 4 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.33e-05 | 86 | 40 | 3 | 2df674969383d93509ea9e201452cfda702fae40 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.33e-05 | 86 | 40 | 3 | 8ead39a100fa5aedf93a2206edd9828538f990a5 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 132 | 40 | 3 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.51e-04 | 137 | 40 | 3 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 144 | 40 | 3 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 149 | 40 | 3 | aedbae2dffa1e880e5c6a146b6d5a135e7f54308 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-MAIT|Leuk-UTI / Disease, Lineage and Cell Type | 3.47e-04 | 153 | 40 | 3 | ac3a1d1b5bf6009df818fd757dad7382d95c60dc | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 156 | 40 | 3 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.68e-04 | 156 | 40 | 3 | d249747c7108a0edfc72d24c09b0b0e4ed662b40 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 3.89e-04 | 159 | 40 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-04 | 159 | 40 | 3 | 57df5c9b678a15eb5e025e1a80de2e6769cc13d5 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.03e-04 | 161 | 40 | 3 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-04 | 163 | 40 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 163 | 40 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-04 | 164 | 40 | 3 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 167 | 40 | 3 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.64e-04 | 169 | 40 | 3 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-04 | 169 | 40 | 3 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-04 | 169 | 40 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.81e-04 | 171 | 40 | 3 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.89e-04 | 172 | 40 | 3 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 172 | 40 | 3 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-04 | 173 | 40 | 3 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.97e-04 | 173 | 40 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-04 | 174 | 40 | 3 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 5.06e-04 | 174 | 40 | 3 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-04 | 174 | 40 | 3 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-04 | 175 | 40 | 3 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 5.14e-04 | 175 | 40 | 3 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.23e-04 | 176 | 40 | 3 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-04 | 176 | 40 | 3 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-04 | 176 | 40 | 3 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-04 | 176 | 40 | 3 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-04 | 177 | 40 | 3 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.31e-04 | 177 | 40 | 3 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-04 | 178 | 40 | 3 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-04 | 178 | 40 | 3 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-04 | 178 | 40 | 3 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-04 | 179 | 40 | 3 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-04 | 179 | 40 | 3 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.49e-04 | 179 | 40 | 3 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-04 | 180 | 40 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-04 | 180 | 40 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.67e-04 | 181 | 40 | 3 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.67e-04 | 181 | 40 | 3 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.76e-04 | 182 | 40 | 3 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-04 | 182 | 40 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | severe-multiplets|World / disease stage, cell group and cell class | 5.76e-04 | 182 | 40 | 3 | 5e30ec7120a988d9ee3000513e1209618f28f5f9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-04 | 182 | 40 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.76e-04 | 182 | 40 | 3 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| Drug | CAS 64485-93-4 | 1.60e-06 | 50 | 39 | 4 | CID000002631 | |
| Drug | etridiazole | 1.60e-06 | 50 | 39 | 4 | CID000017432 | |
| Drug | AC1NS0C1 | 3.11e-06 | 17 | 39 | 3 | CID005326326 | |
| Drug | AC1MXB9R | 4.91e-06 | 66 | 39 | 4 | CID000002172 | |
| Drug | Lowicryl HM20 | 8.04e-06 | 23 | 39 | 3 | CID000174488 | |
| Drug | 2-hydroxycarbazole | 8.57e-06 | 3 | 39 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 8.57e-06 | 3 | 39 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 8.57e-06 | 3 | 39 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 8.57e-06 | 3 | 39 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 8.57e-06 | 3 | 39 | 2 | CID000127713 | |
| Drug | aminodantrolene | 8.57e-06 | 3 | 39 | 2 | CID009570289 | |
| Drug | T0702 | 1.04e-05 | 25 | 39 | 3 | CID000005908 | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A | 1.71e-05 | 189 | 39 | 5 | 3072_UP | |
| Drug | PCB74 | 1.71e-05 | 4 | 39 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 1.71e-05 | 4 | 39 | 2 | CID006444275 | |
| Drug | SC 38249 | 1.71e-05 | 4 | 39 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.71e-05 | 4 | 39 | 2 | CID000035682 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; HL60; HG-U133A | 1.89e-05 | 193 | 39 | 5 | 1774_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.94e-05 | 194 | 39 | 5 | 2206_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.94e-05 | 194 | 39 | 5 | 7354_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.94e-05 | 194 | 39 | 5 | 3867_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.99e-05 | 195 | 39 | 5 | 4676_DN | |
| Drug | sulfamide | 2.02e-05 | 31 | 39 | 3 | CID000082267 | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 3431_UP | |
| Drug | Phenylephrine | 2.11e-05 | 505 | 39 | 7 | ctd:D010656 | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 6476_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Up 200; 6uM; HL60; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 6154_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 6604_UP | |
| Drug | IC261 | 2.18e-05 | 96 | 39 | 4 | CID000003674 | |
| Drug | borate | 2.36e-05 | 98 | 39 | 4 | CID000007628 | |
| Drug | H2DIDS | 2.45e-05 | 33 | 39 | 3 | CID000115184 | |
| Drug | Freund's Adjuvant | 2.77e-05 | 209 | 39 | 5 | ctd:D005620 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 3.47e-05 | 37 | 39 | 3 | CID000009643 | |
| Drug | MBED | 4.27e-05 | 6 | 39 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 4.27e-05 | 6 | 39 | 2 | CID000012008 | |
| Drug | AC1O528X | 4.27e-05 | 6 | 39 | 2 | CID006475857 | |
| Drug | NSC114784 | 4.27e-05 | 6 | 39 | 2 | CID000419425 | |
| Drug | AC1L1GTT | 4.66e-05 | 233 | 39 | 5 | CID000003837 | |
| Drug | noradrealine | 4.82e-05 | 575 | 39 | 7 | CID000000951 | |
| Drug | AC1Q6X9N | 5.09e-05 | 42 | 39 | 3 | CID000072205 | |
| Drug | AC1L1E3B | 5.86e-05 | 44 | 39 | 3 | CID000002622 | |
| Drug | Azumoleno | 5.97e-05 | 7 | 39 | 2 | CID000056259 | |
| Drug | Br2BAPTA | 5.97e-05 | 7 | 39 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 5.97e-05 | 7 | 39 | 2 | CID009547999 | |
| Drug | 4,4'-dithiodipyridine | 6.27e-05 | 45 | 39 | 3 | CID000075846 | |
| Drug | AC1L1IZE | 7.36e-05 | 131 | 39 | 4 | CID000004799 | |
| Drug | brotizolam | 7.95e-05 | 8 | 39 | 2 | CID000002451 | |
| Drug | Mi-1 | 7.95e-05 | 8 | 39 | 2 | CID000198746 | |
| Drug | Trp-Trp | 8.11e-05 | 49 | 39 | 3 | CID000088656 | |
| Drug | C11536 | 9.14e-05 | 51 | 39 | 3 | CID000443249 | |
| Drug | cobalt phthalocyanine | 1.02e-04 | 9 | 39 | 2 | CID000076829 | |
| Drug | N-methyl-DL-aspartic acid | 1.09e-04 | 655 | 39 | 7 | CID000004376 | |
| Drug | Sulcrate | 1.18e-04 | 148 | 39 | 4 | CID006398525 | |
| Drug | pentacene | 1.28e-04 | 10 | 39 | 2 | CID000008671 | |
| Drug | showdomycin | 1.28e-04 | 10 | 39 | 2 | CID000028032 | |
| Drug | PCB 95 | 1.28e-04 | 10 | 39 | 2 | CID000038012 | |
| Drug | Dasatinib | 1.50e-04 | 478 | 39 | 6 | ctd:D000069439 | |
| Drug | PCB 66 | 1.56e-04 | 11 | 39 | 2 | CID000036185 | |
| Drug | R 478 | 1.56e-04 | 11 | 39 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.56e-04 | 11 | 39 | 2 | CID003081323 | |
| Drug | fulvestrant | 1.61e-04 | 484 | 39 | 6 | ctd:C070081 | |
| Drug | Ryanodine | 1.87e-04 | 12 | 39 | 2 | ctd:D012433 | |
| Drug | nonivamide | 1.87e-04 | 12 | 39 | 2 | CID000002998 | |
| Drug | glutamate | 1.89e-04 | 962 | 39 | 8 | CID000000611 | |
| Drug | strontium | 2.16e-04 | 68 | 39 | 3 | CID000104798 | |
| Drug | AC1LCJM3 | 2.20e-04 | 13 | 39 | 2 | CID000631640 | |
| Drug | pioglitazone | 2.25e-04 | 326 | 39 | 5 | CID000004829 | |
| Drug | TMB-8 | 2.30e-04 | 176 | 39 | 4 | CID000005494 | |
| Drug | flecainide | 2.45e-04 | 71 | 39 | 3 | CID000003355 | |
| Drug | iberin | 2.57e-04 | 14 | 39 | 2 | ctd:C082585 | |
| Drug | Fmoc | 2.57e-04 | 14 | 39 | 2 | CID000034367 | |
| Drug | BCECF | 2.66e-04 | 73 | 39 | 3 | CID004241719 | |
| Drug | forskolin from Coleus forskohlii | 2.68e-04 | 1013 | 39 | 8 | CID000003413 | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.78e-04 | 185 | 39 | 4 | 5072_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.89e-04 | 187 | 39 | 4 | 4589_UP | |
| Drug | FPL 64176 | 2.96e-04 | 15 | 39 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 2.96e-04 | 15 | 39 | 2 | CID000125015 | |
| Drug | CT 0 | 2.96e-04 | 15 | 39 | 2 | CID002255489 | |
| Drug | AC1MQSA8 | 3.00e-04 | 76 | 39 | 3 | CID003481670 | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A | 3.01e-04 | 189 | 39 | 4 | 2508_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 3.08e-04 | 190 | 39 | 4 | 6199_UP | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 3.08e-04 | 190 | 39 | 4 | 4452_DN | |
| Drug | propofol | 3.14e-04 | 191 | 39 | 4 | CID000004943 | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 3.26e-04 | 193 | 39 | 4 | 4488_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 3826_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 6833_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 6827_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 5056_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 6308_UP | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.36e-04 | 79 | 39 | 3 | CID005287890 | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 3804_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 6626_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4748_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4396_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 3.39e-04 | 195 | 39 | 4 | 2004_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 6464_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 2101_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 4535_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 5827_DN | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 3383_UP | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Myeloid Leukemia, Chronic | 8.23e-06 | 29 | 40 | 3 | C0023473 | |
| Disease | Colorectal Neoplasms | 3.54e-05 | 277 | 40 | 5 | C0009404 | |
| Disease | Glaucoma | 6.41e-05 | 9 | 40 | 2 | C0017601 | |
| Disease | anemia (implicated_via_orthology) | 1.86e-04 | 15 | 40 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 2.12e-04 | 16 | 40 | 2 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.41e-04 | 17 | 40 | 2 | C0751883 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 3.02e-04 | 19 | 40 | 2 | C0751884 | |
| Disease | Colorectal Carcinoma | 3.42e-04 | 702 | 40 | 6 | C0009402 | |
| Disease | Malignant mesothelioma | 4.39e-04 | 109 | 40 | 3 | C0345967 | |
| Disease | Myasthenic Syndromes, Congenital | 4.85e-04 | 24 | 40 | 2 | C0751882 | |
| Disease | systemic mastocytosis | 5.27e-04 | 25 | 40 | 2 | MONDO_0016586 | |
| Disease | Liver carcinoma | 5.88e-04 | 507 | 40 | 5 | C2239176 | |
| Disease | suicidal ideation | 7.11e-04 | 29 | 40 | 2 | EFO_0004320 | |
| Disease | Kartagener Syndrome | 1.04e-03 | 35 | 40 | 2 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.04e-03 | 35 | 40 | 2 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.04e-03 | 35 | 40 | 2 | C4551906 | |
| Disease | Burkitt Lymphoma | 1.10e-03 | 36 | 40 | 2 | C0006413 | |
| Disease | Primary ciliary dyskinesia | 1.10e-03 | 36 | 40 | 2 | cv:C0008780 | |
| Disease | Mastocytosis | 1.29e-03 | 39 | 40 | 2 | EFO_0009001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKLLLMPAKHQPDLL | 861 | Q96Q91 | |
| LHGTLPKLNFGMLRK | 96 | Q9Y4X3 | |
| QIKKLHDLLGPHMLR | 916 | Q8TDI0 | |
| HLEALLLPMKPLKAA | 516 | P11274 | |
| QNPKKLHLTIGMLVL | 201 | Q8N9N2 | |
| GHIISLKLSPNLRKM | 651 | Q9UI46 | |
| MGKNKLLHPSLVLLL | 1 | P01023 | |
| LTLLIHGSPMDKLKF | 86 | Q96PH1 | |
| MSKHPGLLLILGKLI | 2001 | O14497 | |
| VQPRLKLLLMGHKAA | 406 | Q9Y4C4 | |
| IEPLLKNMALHLKRL | 186 | Q3V6T2 | |
| MTLINLLLKVLGPIH | 361 | Q9H3H5 | |
| ETLGLKPHLLVLNKM | 71 | Q9BT17 | |
| DRPLMLAIHKKILQL | 401 | O15534 | |
| PLMLAIHKKILQSGG | 376 | O15055 | |
| HPKLLAKALEMVPLL | 1491 | P50748 | |
| HLLDMLLTNKKPVLC | 2211 | Q9P2D7 | |
| IGILKMVKHPNILQL | 71 | Q8NCB2 | |
| LGLLVHLMTSNPKIL | 446 | Q9BZC7 | |
| KKHKMARLLPNGLAI | 136 | Q8IUY3 | |
| VPLLNEHAKMPLKLL | 2596 | Q92736 | |
| MFQLLIPLLLALKGH | 1 | A0A1B0GVH4 | |
| QTHLIKPGTKMLTLL | 26 | Q9H7T9 | |
| LALLKMLKHGRAGVP | 36 | O00487 | |
| LPQLKRHIKQLLIDM | 991 | A8MW92 | |
| LPQLKHCIKQLLMDL | 986 | Q9BVI0 | |
| GHIKNVPLILKRMKL | 311 | O43196 | |
| LGLLHGKILSPKDIM | 841 | P35499 | |
| KFVNMLLSHGIKPIL | 61 | Q9UQ84 | |
| QLHLKPGTRLLKMAQ | 521 | Q15003 | |
| PHLAQLTGSKMKLLN | 1501 | Q7Z460 | |
| KPHLSQLTGSKMKLL | 1256 | O75122 | |
| RKKNSGKTPHLLLML | 271 | P61812 | |
| PKKLMHQAALLGQAL | 216 | Q16881 | |
| NEILMLGAKLHPTLK | 311 | Q8NER1 | |
| MKHTLALLAPLLGLG | 1 | Q8N271 | |
| LIVAALKKMLPIGLN | 3366 | Q15413 | |
| LGLSAMKLQKLDLLP | 151 | Q9Y2C9 | |
| MKLQKLDLLPIAHLH | 156 | Q9Y2C9 | |
| LKLLLMPLKHQPDFI | 926 | Q9Y6R1 | |
| LKLHLKMLPSEPVLL | 901 | Q8NI36 |